Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis

[1]  H. Zhang,et al.  Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. , 2013, Journal of molecular and cellular cardiology.

[2]  G. Heusch,et al.  Nitroglycerin does not Interfere with Protection by Remote Ischemic Preconditioning in Patients with Surgical Coronary Revascularization under Isoflurane Anesthesia , 2013, Cardiovascular Drugs and Therapy.

[3]  G. Heusch.  Cardioprotection: chances and challenges of its translation to the clinic , 2013, The Lancet.

[4]  H. Bøtker,et al.  Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients , 2012, Basic Research in Cardiology.

[5]  L. Becker,et al.  Remote ischemic preconditioning confers late protection against myocardial ischemia–reperfusion injury in mice by upregulating interleukin-10 , 2012, Basic Research in Cardiology.

[6]  G. Heusch,et al.  STAT5 Activation and Cardioprotection by Remote Ischemic Preconditioning in Humans , 2012, Circulation research.

[7]  G. Heusch,et al.  Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol – a clinical trial , 2012, Acta anaesthesiologica Scandinavica.

[8]  B. Bein,et al.  Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study , 2012, Basic Research in Cardiology.

[9]  D. Henrion,et al.  RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning , 2011, Basic Research in Cardiology.

[10]  Hongmei Gu,et al.  SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. , 2011, American journal of physiology. Heart and circulatory physiology.

[11]  Richard T. Lee,et al.  Stromal Cell-Derived Factor-1 Retention and Cardioprotection for Ischemic Myocardium , 2011, Circulation. Heart failure.

[12]  D. Yellon,et al.  The therapeutic potential of ischemic conditioning: an update , 2011, Nature Reviews Cardiology.

[13]  M. Mocanu,et al.  Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury , 2011, Journal of cardiovascular pharmacology and therapeutics.

[14]  D. Yellon,et al.  Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. , 2011, Antioxidants & redox signaling.

[15]  Michael Bader,et al.  SDF-1α as a therapeutic stem cell homing factor in myocardial infarction. , 2011, Pharmacology & therapeutics.

[16]  A. K. Jonassen,et al.  Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion , 2010, Basic Research in Cardiology.

[17]  P. Ferdinandy,et al.  Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. , 2010, Cardiovascular research.

[18]  G. Heusch,et al.  Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest , 2010, Basic Research in Cardiology.

[19]  C. Terkelsen,et al.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial , 2010, The Lancet.

[20]  Masafumi Takahashi.  Role of the SDF-1/CXCR4 system in myocardial infarction. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[21]  W. Franz,et al.  Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy , 2010, Expert opinion on biological therapy.

[22]  B. Gersh.  Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial , 2010 .

[23]  Elena Kuzmin,et al.  Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. , 2009, Clinical science.

[24]  Wuqiang Zhu,et al.  Hypoxic Preconditioning Enhances the Benefit of Cardiac Progenitor Cell Therapy for Treatment of Myocardial Infarction by Inducing CXCR4 Expression , 2009, Circulation research.

[25]  M. Matsuzaki,et al.  Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. , 2009, Journal of the American College of Cardiology.

[26]  N. Heveker,et al.  AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties , 2009, Molecular Pharmacology.

[27]  Robert David,et al.  Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. , 2009, Cell stem cell.

[28]  L. Sharples,et al.  Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial , 2009, Circulation.

[29]  D. Wong,et al.  Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside , 2008, Clinical Cancer Research.

[30]  D. Yellon,et al.  Remote ischaemic preconditioning: underlying mechanisms and clinical application. , 2008, Cardiovascular research.

[31]  H. Ly,et al.  Quantitation of CXCR4 Expression in Myocardial Infarction Using 99mTc-Labeled SDF-1α , 2008, Journal of Nuclear Medicine.

[32]  James W. Smyth,et al.  Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction , 2008, Circulation.

[33]  L. Ou,et al.  Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  S. Ogawa,et al.  Stromal cell‐derived factor‐1α improves infarcted heart function through angiogenesis in mice , 2007, Pediatrics international : official journal of the Japan Pediatric Society.

[35]  D. Yellon,et al.  Myocardial reperfusion injury. , 2007, The New England journal of medicine.

[36]  M. Hayward,et al.  Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial , 2007, The Lancet.

[37]  R. Bolli,et al.  Stromal Cell–Derived Factor-1&agr; Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1&agr;–CXCR4 Axis , 2007 .

[38]  J. Nascimento,et al.  Cardioprotective Properties of Humoral Factors Released From Rat Hearts Subject to Ischemic Preconditioning , 2007, Journal of cardiovascular pharmacology.

[39]  E. Deroubaix,et al.  Structural Localization and Expression of CXCL12 and CXCR4 in Rat Heart and Isolated Cardiac Myocytes , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[40]  R. Bolli,et al.  Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. , 2007, Circulation.

[41]  I. Konstantinov,et al.  Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. , 2006, Journal of the American College of Cardiology.

[42]  M. Duchen,et al.  Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. , 2006, The international journal of biochemistry & cell biology.

[43]  Yan Huang,et al.  Stromal Cell–Derived Factor-1α Plays a Critical Role in Stem Cell Recruitment to the Heart After Myocardial Infarction but Is Not Sufficient to Induce Homing in the Absence of Injury , 2004, Circulation.

[44]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[45]  E. Clercq.  The bicyclam AMD3100 story , 2003, Nature Reviews Drug Discovery.

[46]  A. Redington,et al.  Transient Limb Ischemia Induces Remote Ischemic Preconditioning In Vivo , 2002, Circulation.

[47]  E. De Clercq,et al.  Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4 , 2002, FEBS letters.

[48]  E. Dickson,et al.  "Preconditioning at a distance" in the isolated rabbit heart. , 2000, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[49]  G. Wilson,et al.  Comparison of ischaemic preconditioning in blood perfused and buffer perfused isolated heart models. , 1993, Cardiovascular research.